XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Company's stock option activity

Activity under the Company’s stock option plans during the three months ended March 31, 2023 was as follows:

 

 

 

 

 

 

Weighted-

 

 

Weighted-

 

 

Aggregate

 

 

 

 

 

 

Average

 

 

Average

 

 

Intrinsic

 

 

 

Options

 

 

Exercise

 

 

Remaining

 

 

Value

 

 

 

Outstanding

 

 

Price

 

 

Term

 

 

(000’s)

 

Balance at December 31, 2022

 

 

9,757,329

 

 

$

17.79

 

 

 

 

 

 

 

Granted

 

 

2,171,590

 

 

$

19.27

 

 

 

 

 

 

 

Exercised

 

 

(31,810

)

 

$

15.21

 

 

 

 

 

 

 

Forfeited and expired

 

 

(359,995

)

 

$

21.73

 

 

 

 

 

 

 

Balance at March 31, 2023

 

 

11,537,114

 

 

$

17.95

 

 

 

8.2

 

 

$

14,260

 

Vested and expected to vest at March 31, 2023

 

 

11,537,114

 

 

$

17.95

 

 

 

8.2

 

 

$

14,260

 

Exercisable at March 31, 2023

 

 

4,514,770

 

 

$

16.24

 

 

 

6.8

 

 

$

13,495

 

Summary of Company's restricted stock unit activity

The Company’s restricted stock unit activity during the three months ended March 31, 2023 was as follows:

 

 

 

 

 

 

Weighted-

 

 

 

 

Restricted Stock

 

 

Average

 

 

 

 

Units

 

 

Grant Date

 

 

 

Outstanding

 

 

Fair Value

 

 

Balance at December 31, 2022

 

 

290,311

 

 

$

19.88

 

 

Granted

 

 

604,621

 

 

$

19.64

 

 

Vested

 

 

(81,294

)

 

$

19.54

 

 

Forfeited

 

 

(7,238

)

 

$

19.84

 

 

Balance at March 31, 2023

 

 

806,400

 

 

$

19.74

 

 

Weighted Average Assumptions Used to Estimate Fair Value of Stock Awards Granted to Employees The following table summarizes the weighted average assumptions used to estimate the fair value of stock options granted under the Company’s stock option plans for the periods presented below:

 

Stock Option Awards

 

Three months ended March 31,

 

 

2023

 

2022

Expected option term

 

6.0 years

 

6.0 years

Expected volatility

 

67%

 

88%

Risk free interest rate

 

4.2%

 

1.8%

Expected dividend yield

 

%

 

%

Summary of Stock-based Compensation Expense for the Equity Awards Issued to Employees and Non-Employees

Stock-based compensation expense for the equity awards issued by the Company to employees and non-employees for the periods presented below was as follows (in thousands):

 

 

Three months ended March 31,

 

 

2023

 

 

2022

 

Included in research and development

$

4,678

 

 

$

3,191

 

Included in general and administrative

 

3,418

 

 

 

2,564

 

Total stock-based compensation expense

$

8,096

 

 

$

5,755